Product
Janssen
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Randomized, Open-label, Adaptive, Controlled, Phase III Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of Reimmunization With Third Dose of Homologous vs. Heterologous Vaccine Against COVID-19 in Patients Undergoing Solid Organ Transplantation: Liver, Heart, Kidney and Lung.Status: Withdrawn, Estimated PCD: 2021-09-01